Your Trusted Source for Life Sciences Data
Discover emerging life science companies, uncover qualified leads, and identify the right partners faster. By combining expert human curation with AI-driven intelligence, our platform delivers the insights you need to accelerate business development, licensing, and investment decisions with confidence.
Unique data sourcing process
leading to an exclusive data set
Over 1,020,000 regularly
updated clinical trials
68,000 companies with over
370,000 management contact details
Over 43,000 Biotech, Pharma and Medtech
assets available for licensing
Investor Database including
direct contact details
License agreements with payment
structures and original contract
BIOTECHGATE DIGITAL PARTNERING
Virtual business development & licensing event
Join five days of digital partnering, workshops and networking sessions. Establish new global connections thanks to pre-arranged one-on-one Zoom meetings.
Solutions by industry
Biotechgate is a versatile information source
catering to the entire life science industry.
What our clients say
Latest industry news
Innovent Biologics Announces Closing of Global Strategic Partnership with Takeda for Next-Generation IO and ADC Therapies
05 Dec 2025
Read moreIpsen provides update on legacy of Henri Beaufour
05 Dec 2025
Read moreSapu Nano Announce Deciparticle™ Led Biomarker Framework Identifying Tumors Most Likely to Respond to IV Sapu003, an Intravenous Everolimus Nanomedicine
05 Dec 2025
Read moreUpcoming Conferences
10January2026
10January2026
11th Annual Oncology Innovation Forum
San Francisco, USAThe 11th Annual OIF offers a well-established networking platform for senior executives from biotech to meet with pharma licensing teams, corporate and financial investors, and industry advisers. Meetings will run alongside a dynamic programme focused on current trends in pharma-biotech dealmaking, including Chinese deal flow, and investment opportunities across a broad range of therapeutic targets and modalities. All company showcases and panel discussions will be recorded and made available on demand for the virtual audience the week after JPM. The forum will also feature pre-arranged in-person and virtual meetings, live and on-demand company presentations, and a networking reception.
Read more 11January2026
11January2026
9th Annual Neuroscience Innovation Forum
San Francisco, USAPositioned at the beginning of JPM week, the NIF forum focuses on the latest developments across key areas of neuroscience, which are currently attracting record investor interest and deal flow. The main programme for the 9th Annual NIF will feature more than 8 hours of high-level keynotes and panel discussions addressing the important advances in therapeutic, neurotech, and diagnostics fields.
Delegates from Venture Valuation and Biotechgate will attend the event.
Read more 12January2026
13January2026
RESI JPM 2026
San Francisco, USAThe RESI Conference will be held on January 12-13 at the San Francisco Marriott Marquis, featuring two days in-person event followed by three days (January 14, 19&20) of online partnership activities. Previous RESI JPM conferences have drawn over a thousand attendees, including more than 500 early-stage life science investors, innovators, and industry experts. This RESI is held concurrently with JP Morgan Healthcare Week which will take place from January 12-15, 2026, at the Westin St. Francis in San Francisco. As the largest and most comprehensive healthcare investment symposium, it attracts thousands of life science professionals globally.
Delegates from Venture Valuation and Biotechgate will attend the event.
Read more